Markets › United States › NAS › SPRY

ARS Pharmaceuticals Inc

NAS:SPRYHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$4.02−1.23%At closeAt close · Sat 17 Oct · ≈ AED 14.76 · Market cap $399.78M · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	21.1%	96.1%	−1,200.9%	100.0%	76.9%	75.8%	—	—
Operating margin	−2.6%	−353.3%	−2,698.8%	−225,066.7%	−3.5%	−212.9%	−212.9%	+0.0 pts
Net margin	−6.0%	−367.7%	−2,635.4%	−181,216.7%	9.0%	−203.3%	−203.3%	+0.0 pts
EBITDA margin	−2.6%	−361.9%	−2,611.2%	−180,973.3%	9.4%	−198.6%	—	—
Return on equity	7.6%	64.7%	−12.7%	−23.6%	3.1%	−149.9%	−149.9%	+0.0 pts
Return on assets	−4.0%	−32.9%	−12.3%	−23.3%	2.3%	−52.3%	−52.3%	+0.0 pts
Return on capital employed	−2.6%	−36.5%	−12.9%	−29.3%	−0.9%	−62.2%	—	—
Debt / equity	−0.7×	−0.3×	0.0×	0.0×	0.0×	0.8×	0.8×	+0.0%
Debt / assets	37.9%	14.7%	0.2%	0.1%	0.0%	29.4%	—	—
Interest coverage	−16.2×	−183.5×	0.0×	0.0×	0.0×	−69.0×	—	—
Current ratio	3.2×	7.4×	51.0×	96.8×	14.3×	7.3×	7.3×	+0.0%
Quick ratio	3.2×	7.4×	51.0×	96.8×	14.0×	7.1×	—	—
Cash ratio	3.0×	7.3×	38.7×	29.7×	2.2×	1.1×	1.1×	+0.0%
Asset turnover	0.7×	0.1×	0.0×	0.0×	0.3×	0.3×	—	—
Inventory turnover	—	—	—	—	3.9×	2.4×	—	—
Receivables turnover	46.4×	5,506.0×	—	0.0×	9.7×	3.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—